Global Irritable Bowel Syndrome Treatment Market: Restraint
The major factors that hinder growth of the global irritable bowel syndrome treatment market include side effects of the drugs. For instance, Eluxadoline, a mixed mu-opioid receptor agonist, used to treat irritable bowel syndrome with diarrhea can cause pancreatitis, an inflammation of the pancreas which can be serious and more common in certain individuals.
Irritable Bowel Syndrome Treatment Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients